ResearcherLeiden University Medical CenterActive in the last 2 years
Vera Kemp
Matched on ORCID iD 0000-0003-4910-4655; OpenAlex author ID A5061304621. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2024: 2 papers · 2025: 1 paper · 2026: 1 paper
Papers 4
- Bulk RNA sequencing deconvolution of early-onset pancreatic ductal adenocarcinoma identifies cancer-associated fibroblast subsets associated with survival and … Co-author DOI 10.1016/j.ctarc.2026.101490↗
- ZEB1, a novel junctional adhesion molecule A regulator, impacts sensitivity of pancreatic cancer-associated fibroblasts to reovirus. Last author DOI 10.1016/j.omton.2025.201071↗
- Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/1878-0261.13561↗
- Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures. Co-author DOI 10.1016/j.ebiom.2024.105219↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lukas J.A.C. Hawinkels · 3 shared papers, 2024–2026 · strength 0.73
- Paper Bulk RNA sequencing deconvolution of early-onset pancreatic ductal adenocarcinoma identifies cancer-associated fibrobla… DOI 10.1016/j.ctarc.2026.101490↗
- Paper ZEB1, a novel junctional adhesion molecule A regulator, impacts sensitivity of pancreatic cancer-associated fibroblasts… DOI 10.1016/j.omton.2025.201071↗
- Paper Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures. DOI 10.1016/j.ebiom.2024.105219↗
- Nicole Dam · 2 shared papers, 2025–2026 · strength 0.58
- Paper Bulk RNA sequencing deconvolution of early-onset pancreatic ductal adenocarcinoma identifies cancer-associated fibrobla… DOI 10.1016/j.ctarc.2026.101490↗
- Paper ZEB1, a novel junctional adhesion molecule A regulator, impacts sensitivity of pancreatic cancer-associated fibroblasts… DOI 10.1016/j.omton.2025.201071↗
- Tom J. Harryvan · 2 shared papers, 2024–2025 · strength 0.52
- Paper ZEB1, a novel junctional adhesion molecule A regulator, impacts sensitivity of pancreatic cancer-associated fibroblasts… DOI 10.1016/j.omton.2025.201071↗
- Paper Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pa… DOI 10.1002/1878-0261.13561↗
- Rob C. Hoeben · 2 shared papers, 2024 · strength 0.39
- Selas T. F. Bots · 2 shared papers, 2024 · strength 0.39
- Bram W. van Os · 1 shared paper, 2026 · strength 0.30
- Willem de Koning · 1 shared paper, 2026 · strength 0.30
- Gaby J. Strijk · 1 shared paper, 2026 · strength 0.30
- Casper H.J. van Eijck · 1 shared paper, 2026 · strength 0.30
- Florian Gebauer · 1 shared paper, 2024 · strength 0.15
- Christine E. Engeland · 1 shared paper, 2024 · strength 0.15
- Claudia R. Ball · 1 shared paper, 2024 · strength 0.15
- Guy Ungerechts · 1 shared paper, 2024 · strength 0.15
- Theresa E. Schäfer · 1 shared paper, 2024 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.